Technicals for Torrent Pharmaceuticals Limited
The PSAR for TORNTPHARM continues to indicate a bearish outlook, reinforcing a...
More about Torrent Pharmaceuticals Limited
Fundamentals for Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Limited had 1 buy transactions, with market price at 3224.449951171875...
Regulatory Filings for Torrent Pharmaceuticals Limited
The list of all important regulatory filings for Torrent Pharmaceuticals Limited which...
Expense Surge or Growth Engine? Investor Implications of JPMorgan's 2026 Spending Plan
An analysis of JPMorgan Chase's $105 billion 2026 expense guidance, exploring its...
Corporate Leaders Double Down on AI, Talent and Customer Personalisation
An investor-oriented article synthesising corporate leaders’ optimism for 2025 and the top...
Financial Services in Flux: Debanking, Cost Pressures and the Rise of Crypto Prediction Markets
An investor-focused analysis of major shifts in the financial services landscape as...
Regulatory Filings for Torrent Pharmaceuticals Limited
Recent filings by Torrent Pharmaceuticals Limited
| Published | Title | Summary |
|---|---|---|
| 2025-09-10 16:37:26 | Acquisition | Torrent Pharmaceuticals Limited has informed the Exchange about Acquisition... |
| 2025-05-20 17:45:10 | Record Date | Torrent Pharmaceuticals Limited has informed the Exchange that Record date... |
| 2025-01-24 16:46:02 | Dividend | Torrent Pharmaceuticals Limited has informed the Exchange that Board of... |
| 2025-01-13 18:47:01 | Record Date | Torrent Pharmaceuticals Limited has informed the Exchange that Record date... |
| 2025-01-13 18:45:50 | Board Meeting Intimation | Torrent Pharmaceuticals Limited has informed the Exchange about Board Meeting... |
| 2024-10-10 14:45:39 | Board Meeting Intimation | TORRENT PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting... |
| 2024-05-24 18:31:10 | Dividend Updates | Torrent Pharmaceuticals Limited has informed the Exchange about Dividend Updates... |
| 2024-05-24 17:51:38 | Dividend | Torrent Pharmaceuticals Limited has informed the Exchange that Board of... |
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Lists of companies in NSE500 with the best and the worst fundamentals...
Latest Regulatory Filings for NSE500
List of the latest important filings for NSE500....
Companies with the best and the worst technicals.
Lists of companies in NSE500 with the best and the worst technicals...
Tariffs, Trade Disruption, and the Rise of Resilient Supply Chain Models
An article analysing how new U.S. tariff policies are contributing to economic...
The Oracle Paradox: AI Backlog Boom Meets Revenue Miss
An article exploring Oracle’s latest quarterly results that reveal a significant AI...
From Rate Cuts to Asset Purchases: Decoding the Fed’s 2025 Finale for the 2026 Outlook
An in-depth article analysing the Federal Reserve’s December 2025 rate cut and...